Search results
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 6 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Cantor Fitzgerald
ETF DAILY NEWS· 8 hours agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a note issued to investors on Monday, Benzinga reports ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 6 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Citizens Business Bank Sells 329 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoCitizens Business Bank lowered its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 8.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
KFA Private Wealth Group LLC Buys 164 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoKFA Private Wealth Group LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities ...